AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.300
-0.010 (-0.76%)
At close: Oct 8, 2025, 4:00 PM EDT
1.290
-0.010 (-0.77%)
After-hours: Oct 8, 2025, 4:00 PM EDT
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $35.52 million as of October 8, 2025. Its market cap has increased by 13.37% in one year.
Market Cap
35.52M
Enterprise Value
-27.12M
1-Year Change
13.37%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $35.52M, a decrease of -87.36%. That is a compound annual growth rate of -44.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 35.80M | -13.18% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 765.84B |
| Johnson & Johnson | 453.44B |
| AbbVie | 404.35B |
| UnitedHealth Group | 327.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 233.43B |